Biotech Medicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-08-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-08-2024
- Company Age 25 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -38.80%
(FY 2023)
- Profit -49.83%
(FY 2023)
- Ebitda -97.73%
(FY 2023)
- Net Worth 3.30%
(FY 2023)
- Total Assets 46.50%
(FY 2023)
About Biotech Medicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Indira Rajupusapati, Mahima Datla, Mahipal Saddi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230TG1999PTC032680
- Company No.
032680
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 1999
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Himayatnagar,Hyderabad - 29., Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Biotech Medicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Indira Rajupusapati  | Additional Director | 12-Apr-2013 | Current |
| Mahima Datla | Director | 30-Sep-2011 | Current |
| Mahipal Saddi | Director | 21-Nov-2017 | Current |
| Rudaraju Kumar | Director | 21-Nov-2017 | Current |
Financial Performance and Corporate Structure Insights of Biotech Medicals.
Biotech Medicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 38.8% decrease. The company also saw a substantial fall in profitability, with a 49.83% decrease in profit. The company's net worth moved up by a moderate rise of 3.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotech Medicals?
In 2022, Biotech Medicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biological E. LimitedActive 71 years 10 daysIndira Rajupusapati, Mahima Datla and 1 more are mutual person
- Vaxenic India Private LimitedActive 9 years 10 months
Indira Rajupusapati, Mahima Datla and 1 more are mutual person
Be Pharmaceuticals Private LimitedActive 13 years 3 monthsMahima Datla, Mahipal Saddi and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biotech Medicals?
Unlock and access historical data on people associated with Biotech Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
